Ixchiq
What Ixchiq is used for
Ixchiq is indicated for active immunisation for the prevention of disease caused by chikungunya virus (CHIKV) in individuals 12 years and older at high risk of acquiring chikungunya infection. The use of this vaccine should be in accordance with official recommendations.
Approved use, as published by the European Medicines Agency.
What the labels mean
- PRIME: a priority medicine that the EMA supported early because it may meet an unmet need.
Key facts
- Brand
- Ixchiq
- Active substance
- Chikungunya vaccine (live)
- Disease area
- Chikungunya virus
- Medicine group
- Vaccines
- ATC code
- J07BP01
- Marketing authorisation holder
- Valneva Austria GmbH
- Authorised in the EU since
- 2024
Official information
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Ixchiq used for?
Ixchiq is indicated for active immunisation for the prevention of disease caused by chikungunya virus (CHIKV) in individuals 12 years and older at high risk of acquiring chikungunya infection. The use of this vaccine should be in accordance with official recommendations.
What is the active substance in Ixchiq?
Ixchiq contains Chikungunya vaccine (live).
Who makes Ixchiq?
The EU marketing authorisation holder is Valneva Austria GmbH.
Source: European Medicines Agency medicines data (ema.europa.eu), reproduced with acknowledgement of the source. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, EU